Delivery Order SPE2DB24D2010-SPE2DB26FZRX5
- Not listed
- The Defense Logistics Agency awarded a $3,604.57 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of 1,000 tablets of Pantoprazole Sodium delayed-release 40 mg. This competitive delivery order, which is set to be completed by September 18, 2025, represents a firm fixed-price transaction issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX, valued at $999,999,999.00 through December 2026). The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a quantity of 1,000 units, with a ceiling value of $5,258.71. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 15, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a quantity of 1,000 units, with a ceiling value of $3,309.50. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Pantoprazole Sodium Delayed-Release 40 mg tablets in a quantity of 1,000 units, with a ceiling value of $2,058.66. This competitive award, which utilizes firm fixed price pricing, represents a non-set-aside contract and is scheduled for completion by August 29, 2025. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,119.58 to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in quantities of 1,000 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract is scheduled for ultimate completion on September 17, 2025, with performance occurring at the vendor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a quantity of 1,000 units, with a ceiling value of $1,089.14. This is a firm fixed-price, non-set-aside contract with performance completion scheduled for September 15, 2025, and fulfillment to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a quantity of 1,000 units, with a contract ceiling value of $1,083.78. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The product will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Pantoprazole Sodium Delayed-Release 40 mg tablets in a quantity of 1,000 units, with a ceiling value of $2,535.19. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for ultimate completion on September 23, 2025, and will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a quantity of 1,000 units, with a ceiling value of $1,129.71. This contract represents a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and was awarded without set-aside provisions through open competition. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a quantity of 1,000 units, with a contract value of $1,013.16. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively awarded. The order is set for ultimate completion on August 1, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken,...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB26FZRX5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,786.98 to AmerisourceBergen Drug Corp for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in quantities of 1,000 units. This is a firm fixed-price contract with no set-aside designation, reflecting a competitively awarded transaction. The delivery order was executed on October 17, 2025, with an ultimate completion date of October 20, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The Pantoprazole supply supports federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with the DLA planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts with multiple regional awards in coming cycles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 10/17/25 |